B · Normal
[Hisco: Class 1 new drugs cligabalin besylate capsules and colagliptin tablets have been included in the National Medical Insurance Catalog] On November 16th, Hisco (002653.SZ) announced that the company’s Class 1 new drugs cligabalin besylate capsules and colagliptin tablets have been included in the National Medical Insurance Catalog (2026 Edition). Krigabalin besylate capsules are suitable for the treatment of diabetic peripheral neuropathic pain and post-herpetic neuralgia in adults, and colagliptin tablets are suitable for improving blood sugar control in adults with type 2 diabetes. The agreement is valid from January 1, 2027 to December 31, 2028. This inclusion will be conducive to the marketing of innovative pharmaceutical products and play a positive role in product sales.
Comments